Published in Curr Neuropharmacol on March 01, 2011
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology (2011) 2.94
The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol (2012) 2.67
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology (2012) 2.28
Psychoactive "bath salts": not so soothing. Eur J Pharmacol (2012) 1.47
The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts" J Addict Res Ther (2012) 1.10
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. J Neurochem (2013) 0.96
Emerging drugs of abuse: current perspectives on substituted cathinones. Subst Abuse Rehabil (2014) 0.83
Death following ingestion of methylone. Int J Legal Med (2015) 0.80
Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse. Psychopharmacology (Berl) (2014) 0.80
Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. Life Sci (2013) 0.80
Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cells. Sci Rep (2015) 0.75
From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta (1993) 1.89
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol (2006) 1.85
Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol (1999) 1.73
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) (2006) 1.66
Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav (1997) 1.64
Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol (2000) 1.46
Pharmacological content of tablets sold as "ecstasy": results from an online testing service. Drug Alcohol Depend (2005) 1.28
Methylone and mCPP, two new drugs of abuse? Addict Biol (2005) 0.99
Combined intoxication with methylone and 5-MeO-MIPT. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.98
5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. Toxicol Lett (2007) 0.92
[Analysis of designer drugs detected in the products purchased in fiscal year 2006]. Yakugaku Zasshi (2008) 0.89
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch Toxicol (2008) 0.89
MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters. Biochim Biophys Acta (1998) 0.87
The disposition into hair of new designer drugs; methylone, MBDB and methcathinone. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.87
Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005. Forensic Sci Int (2006) 0.86
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. J Clin Oncol (2007) 2.35
Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2. J Am Chem Soc (2003) 1.87
Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry (2008) 1.72
The involvement of glucocorticoids in psychological stress-induced exacerbations of experimental allergic asthma. Int Arch Allergy Immunol (2014) 1.43
Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology (2004) 1.41
Novel reference molecules for quantitation of genetically modified maize and soybean. J AOAC Int (2002) 1.41
URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci Int (2012) 1.36
Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Test Anal (2013) 1.28
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int (2010) 1.25
Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull (Tokyo) (2009) 1.23
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol (2008) 1.23
How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci (2005) 1.22
Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics (2008) 1.19
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry (2007) 1.17
Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice. Neuropsychopharmacology (2004) 1.15
Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia. Biol Psychiatry (2005) 1.15
Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin. Clin Cancer Res (2005) 1.14
Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J Biol Chem (2008) 1.12
Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain (2009) 1.11
Apple procyanidin oligomers absorption in rats after oral administration: analysis of procyanidins in plasma using the porter method and high-performance liquid chromatography/tandem mass spectrometry. J Agric Food Chem (2006) 1.11
Survey of current trends in the abuse of psychotropic substances and plants in Japan. Leg Med (Tokyo) (2011) 1.11
Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology (2006) 1.09
Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys? Neurosci Res (2002) 1.06
Association study of polymorphisms in the 5' upstream region of human DISC1 gene with schizophrenia. Neurosci Lett (2004) 1.06
Characterization of phenolic constituents from ephedra herb extract. Molecules (2013) 1.06
Distinct mechanisms for spiro-carbon formation reveal biosynthetic pathway crosstalk. Nat Chem Biol (2013) 1.02
Detection of recombinant DNA segments introduced to genetically modified maize (Zea mays). J Agric Food Chem (2002) 1.02
Validation of real-time PCR analyses for line-specific quantitation of genetically modified maize and soybean using new reference molecules. J AOAC Int (2002) 1.02
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology (2006) 1.01
Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci (2004) 1.00
Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery. PLoS One (2009) 1.00
mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. Brain Res Mol Brain Res (2004) 1.00
Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol (2007) 1.00
Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. Int J Neuropsychopharmacol (2012) 0.99
Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry (2010) 0.99
Dietary unripe apple polyphenol inhibits the development of food allergies in murine models. FEBS Lett (2005) 0.97
Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia (2010) 0.96
Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett (2003) 0.94
Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice. Anesthesiology (2004) 0.93
dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice. Eur J Pharmacol (2006) 0.93
Detection of DOPA 4,5-dioxygenase (DOD) activity using recombinant protein prepared from Escherichia coli cells harboring cDNA encoding DOD from Mirabilis jalapa. Plant Cell Physiol (2009) 0.93
Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice. Neuropharmacology (2009) 0.92
Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin Exp Res (2006) 0.92
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry (2007) 0.92
Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development. J Bone Miner Metab (2005) 0.91
Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am J Med Genet B Neuropsychiatr Genet (2005) 0.91
Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis. Biol Psychiatry (2007) 0.91
Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain (2004) 0.91
Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol (2009) 0.91
Association of neural cell adhesion molecule 1 gene polymorphisms with bipolar affective disorder in Japanese individuals. Biol Psychiatry (2004) 0.90
A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. Am J Med Genet B Neuropsychiatr Genet (2005) 0.90
Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. Int J Neuropsychopharmacol (2005) 0.90
UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome. Biomed Chromatogr (2014) 0.90
Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations. Hum Genet (2006) 0.90
Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci (2004) 0.90
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology (Berl) (2007) 0.90
MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation. J Neurosci (2012) 0.89
[Analysis of designer drugs detected in the products purchased in fiscal year 2006]. Yakugaku Zasshi (2008) 0.89
Impaired cliff avoidance reaction in dopamine transporter knockout mice. Psychopharmacology (Berl) (2013) 0.89
Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter. Int J Cancer (2008) 0.89
A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neurosci Lett (2004) 0.89
Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence. Ann N Y Acad Sci (2004) 0.88
Biofilm formation by a fimbriae-deficient mutant of Actinobacillus actinomycetemcomitans. Microbiol Immunol (2003) 0.88
Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA. Gene (2005) 0.88
Evaluation of the taste of crude drug and Kampo formula by a taste-sensing system (4): taste of Processed Aconite Root. J Nat Med (2010) 0.88
Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology (2009) 0.88
Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction. Ann N Y Acad Sci (2004) 0.88
Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain. Neurosci Lett (2007) 0.87
Decreased response to social defeat stress in μ-opioid-receptor knockout mice. Pharmacol Biochem Behav (2011) 0.87
The disposition into hair of new designer drugs; methylone, MBDB and methcathinone. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.87
Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity. Pharmacogenet Genomics (2006) 0.87
Simultaneous determination of 11 designated hallucinogenic phenethylamines by ultra-fast liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.87
A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.87
Effect of connective tissue growth factor (CCN2/CTGF) on proliferation and differentiation of mouse periodontal ligament-derived cells. Cell Commun Signal (2005) 0.87
Animal models of attention-deficit/hyperactivity disorder. Biol Pharm Bull (2011) 0.87
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats. Forensic Sci Int (2011) 0.86
Identification of csypyrone B2 and B3 as the minor products of Aspergillus oryzae type III polyketide synthase CsyB. Bioorg Med Chem Lett (2012) 0.86
Structure-based engineering of a plant type III polyketide synthase: formation of an unnatural nonaketide naphthopyrone. J Am Chem Soc (2007) 0.86
Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence. Neurosci Lett (2006) 0.86
Herbacetin, a constituent of ephedrae herba, suppresses the HGF-induced motility of human breast cancer MDA-MB-231 cells by inhibiting c-Met and Akt phosphorylation. Planta Med (2013) 0.86
Comparison of the major flavonoid content of S. baicalensis, S. lateriflora, and their commercial products. J Nat Med (2008) 0.86
Evaluation of the botanical origin of black cohosh products by genetic and chemical analyses. Biol Pharm Bull (2014) 0.86
Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population. Ann N Y Acad Sci (2008) 0.85
Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT). Neurochem Int (2004) 0.85
Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Brain Res (2006) 0.85
Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res (2003) 0.85
PROKR2 is associated with methamphetamine dependence in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.84
Bisnicalaterines B and C, atropisomeric bisindole alkaloids from Hunteria zeylanica, showing vasorelaxant activity. J Org Chem (2010) 0.84
Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusers. Am J Med Genet B Neuropsychiatr Genet (2004) 0.84
Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life Sci (2006) 0.84
Increased body weight in mice lacking mu-opioid receptors. Neuroreport (2006) 0.84